Consumer News Coronavirus Update Pfizer S Vaccine 95 Percent Effective Production Issues Could Inhibit Vaccine Distribution

Final analysis: Pfizer's COVID-19 vaccine 95% effective, company to seek authorization within 'days'

A final analysis of a COVID-19 vaccine candidate produced by Pfizer and BioNTech shows that the drug is 95% effective in preventing the coronavirus, and the companies say they hope to apply for ... Read More

Pfizer's COVID-19 vaccine: What are the side effects? Who will get it first? Here's what we know

The US Food and Drug Administration has issued emergency use authorization (EUA) for the Covid-19 vaccine developed by Pfizer and BioNTech. After months of development, emergency use was authorized ... Read More

Pfizer leads COVID-19 vaccine peers lower after revamped guidance

Pfizer (PFE) stock falls, and its COVID vaccine peers such as Moderna (MRNA) and Novavax (NVAX) also drop as the company issues a disappointing outlook. Read more here. Read More

CDC advisers to review data on Pfizer-BioNTech COVID-19 vaccine

(Reuters) - A U.S. Centers for Disease Control and Prevention (CDC) advisory panel will meet on Friday to review data on the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE, with a vote ... Read More

White House Threatens to Fire FDA Chief Unless Pfizer Covid Vaccine Approved Friday, Reports Say

White House chief of staff Mark Meadows told the head of the Food and Drug Administration to submit his resignation if the agency doesn't clear Pfizer's coronavirus vaccine for emergency use by day's ... Read More

Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026.

Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. Keep your expectations in check. Read More